Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.13), $0.12 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $55.1 million versus the consensus estimate of $48.06 million.

GUIDANCE:

Veracyte sees FY2021 revenue of $200-208 million, versus the consensus of $197.9 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.